Howard Spindel - 09 Jun 2026 Form 4 Insider Report for Pharma-Bio Serv, Inc. (PBSV)

Reporting relationship: Director
Issuer ticker: PBSV
Reported as of: 09 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jul 2026, 20:31:07 UTC
Prior SEC filing: 14 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Howard Spindel

Key filing fact

Howard Spindel filed Form 4 for Pharma-Bio Serv, Inc. (PBSV) on 22 Jul 2026.

Key facts

This page summarizes Howard Spindel's Form 4 filing for Pharma-Bio Serv, Inc. (PBSV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Jul 2026, 20:31.

Change

Previous filing in this sequence was filed on 14 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001351559 Primary reporting owner

SPINDEL HOWARD

Relationship: Director
Address: 7000 WEST PALMETTO PARK ROAD, SUITE 503, BOCA RATON
Signature: /s/ Howard Spindel
Signature date: 22 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PBSV transaction

Common Stock

Other

Transaction value
Shares: -42,504
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 09 Jun 2026
Ownership: By Spouse
Footnotes: F1

PBSV holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 0
Date: 09 Jun 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Following the death of the reporting person's spouse, such shares were transferred to the reporting person's adult children. The reporting person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.